Microneedle Drug Delivery Systems Market (By Type: Solid, Hollow, Dissolving, Coated; By Material: Silicon, Metal, Polymer; By Application: Dermatology, Drug Delivery, Pain Management, Cancer Therapy, Vaccine Delivery) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Microneedle Drug Delivery Systems market gathered revenue around USD 6.50 billion in 2021 and market is set to grow USD 10.9 billion by the end of 2030 and is estimated to expand at a modest CAGR of 6.1% during the prediction period 2022 to 2030.

Growth Factors:

There is a growing demand for microneedle drug delivery systems owing to the availability of safer alternatives to the conventional hypodermic injection, which is minimally invasive and enables pain-free administration. The current global scenario, where the COVID-19 vaccine is in high demand, is expected to offer growth opportunities for microneedles. In addition, the increasing cases of diabetes are expected to boost the market growth.

The growing demand for safer alternatives to the conventional hypodermic injection and increasing awareness regarding minimally invasive and pain-free administration of drugs are expected to boost the market growth. Furthermore, the increasing cases of diabetes are expected to boost the market growth. For instance, according to the International Diabetes Federation (IDF), the number of diabetics has already reached 463 million and is predicted to rise in the next 10 years.

Drug delivery via microneedles is one of the most efficient procedures compared to traditional hypodermic injections. Microneedles are a self-administering platform for transdermal medication delivery that has a high drug bioavailability. The microneedle design and drug formulation can control the dose, delivery rate, and efficacy of the medications. Microneedle also helps reduce or eliminate biohazardous sharps waste. In the coming years, microneedles are expected to have a greater impact on clinical care.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Microneedle Drug Delivery Systems market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Microneedle Drug Delivery Systems market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

Report Coverage

Report Scope Details
Market Size USD  10.9 billion  by 2030
Growth Rate CAGR of 6.1% From 2022 to 2030
Base Year 2021
Forecast Period 2022 to 2030
Report coverage Growth Factors, Revenue Status, Competitive Landscape,  and Future Trends
Segments Covered Type, disease type, procedure, Region Type
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Raphas; Novartis International AG; Becton Dickinson and Company; B. Braun; Nanopass Technologies Limited; Termo; Smiths Medical; Cardinal Health; 3M

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Microneedle Drug Delivery Systems market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

Regional Insights:

North America dominated the market and accounted for a revenue share of over 41.2% in 2021. Patient outcomes and safety are of utmost importance in the U.S., and different projects have been formed to improve healthcare quality and reduce costs. Another factor contributing to the market's rise is the fact that North America spends significantly more on health care than any other country.

In Asia Pacific, the market is estimated to register the fastest CAGR during the forecast period. The spread of the COVID-19 pandemic across APAC has highlighted shortcomings and faults in the region's healthcare system and the interconnectedness between health security and economic stability. As a result, the region is moving closer to achieving its goal of universal health care (UHC). Furthermore, in this region, the technology has attracted the curiosity of patients, healthcare professionals, and companies. In the coming years, microneedles are expected to have a greater impact on clinical care in APAC.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers

Some of the prominent players in the Microneedle Drug Delivery Systems Market include:  Raphas; Novartis International AG; Becton Dickinson and Company; B. Braun; Nanopass Technologies Limited; Termo; Smiths Medical; Cardinal Health; 3M

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of Microneedle Drug Delivery Systems to 2030 and covers subsequent region in its scope:

  • By Type
    • Solid
    • Hollow
    • Dissolving
    • Coated
    • Others
  • By Material
    • Silicon
    • Metal
    • Polymer
    • Others
  • By Application
    • Dermatology
    • Drug Delivery
    • Pain Management
    • Cancer Therapy
    • Vaccine Delivery
    • Others

By Geography

North America

  • U.S.
  • Canada


  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Highlights of the Report:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market

Research Methodology

In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Microneedle Drug Delivery Systems market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the Microneedle Drug Delivery Systems market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Microneedle Drug Delivery Systems markets more accurate and reliable.

Secondary Research

It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
  • In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Industry participants involved in this research study include:

  • CEOs, VPs, market intelligence managers
  • Procuring and national sales managers technical personnel, distributors and resellers
  • Research analysts and key opinion leaders from various domains

Key Points Covered in Microneedle Drug Delivery Systems Market Study:

  • Growth of Microneedle Drug Delivery Systems in 2022
  • Market Estimates and Forecasts (Microneedle Drug Delivery Systems-2030)
  •  Brand Share and Market Share Analysis
  •  Key Drivers and Restraints Shaping Market Growth
  •  Segment-wise, Country-wise, and Region-wise Analysis
  •  Competition Mapping and Benchmarking
  •  Recommendation on Key Winning Strategies
  •  COVID-19 Impact on Demand for Microneedle Drug Delivery Systems and How to Navigate
  •  Key Product Innovations and Regulatory Climate
  •  Microneedle Drug Delivery Systems Consumption Analysis
  •  Microneedle Drug Delivery Systems Production Analysis
  •  Microneedle Drug Delivery Systems and Management